ARTICLE | Company News

I.D. Biomedical Corp., University of British Columbia deal

April 24, 2000 7:00 AM UTC

IDBE received an exclusive worldwide license to oral vaccine delivery technology developed at the university. The parties will use the technology, which is based on a mechanism that the E. coli bacter...